688 related articles for article (PubMed ID: 24423116)
1. Adoptive immunotherapy for cancer or viruses.
Maus MV; Fraietta JA; Levine BL; Kalos M; Zhao Y; June CH
Annu Rev Immunol; 2014; 32():189-225. PubMed ID: 24423116
[TBL] [Abstract][Full Text] [Related]
2. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
3. 'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes.
Ando M; Nakauchi H
Exp Hematol; 2017 Mar; 47():2-12. PubMed ID: 27826124
[TBL] [Abstract][Full Text] [Related]
4. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.
Kalos M; June CH
Immunity; 2013 Jul; 39(1):49-60. PubMed ID: 23890063
[TBL] [Abstract][Full Text] [Related]
5. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
6. Molecular immunology lessons from therapeutic T-cell receptor gene transfer.
Thomas S; Stauss HJ; Morris EC
Immunology; 2010 Feb; 129(2):170-7. PubMed ID: 20561357
[TBL] [Abstract][Full Text] [Related]
7. Targeting cancer-specific mutations by T cell receptor gene therapy.
Blankenstein T; Leisegang M; Uckert W; Schreiber H
Curr Opin Immunol; 2015 Apr; 33():112-9. PubMed ID: 25728991
[TBL] [Abstract][Full Text] [Related]
8. Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions.
Curran KJ; Pegram HJ; Brentjens RJ
J Gene Med; 2012 Jun; 14(6):405-15. PubMed ID: 22262649
[TBL] [Abstract][Full Text] [Related]
9. Engineered T cells for anti-cancer therapy.
Turtle CJ; Hudecek M; Jensen MC; Riddell SR
Curr Opin Immunol; 2012 Oct; 24(5):633-9. PubMed ID: 22818942
[TBL] [Abstract][Full Text] [Related]
10. Adoptive immunotherapy for cancer.
Ruella M; Kalos M
Immunol Rev; 2014 Jan; 257(1):14-38. PubMed ID: 24329787
[TBL] [Abstract][Full Text] [Related]
11. The use of endogenous T cells for adoptive transfer.
Yee C
Immunol Rev; 2014 Jan; 257(1):250-63. PubMed ID: 24329802
[TBL] [Abstract][Full Text] [Related]
12. Principles for adoptive T cell therapy of human viral diseases.
Riddell SR; Greenberg PD
Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
[TBL] [Abstract][Full Text] [Related]
13. Engineered T cells: the promise and challenges of cancer immunotherapy.
Fesnak AD; June CH; Levine BL
Nat Rev Cancer; 2016 Aug; 16(9):566-81. PubMed ID: 27550819
[TBL] [Abstract][Full Text] [Related]
14. Genetically Engineered Natural Killer Cells as a Means for Adoptive Tumor Immunotherapy.
Michen S; Temme A
Crit Rev Immunol; 2016; 36(4):329-347. PubMed ID: 28322137
[TBL] [Abstract][Full Text] [Related]
15. Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.
Rath JA; Arber C
Cells; 2020 Jun; 9(6):. PubMed ID: 32570906
[TBL] [Abstract][Full Text] [Related]
16. Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.
Udyavar A; Geiger TL
Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):335-46. PubMed ID: 20680493
[TBL] [Abstract][Full Text] [Related]
17. Advances in T-cell Immunotherapies.
Stroncek DF; Reddy O; Highfill S; Panch SR
Hematol Oncol Clin North Am; 2019 Oct; 33(5):825-837. PubMed ID: 31466607
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of virus-specific and tumor-specific T cell immunity.
Berger C; Turtle CJ; Jensen MC; Riddell SR
Curr Opin Immunol; 2009 Apr; 21(2):224-32. PubMed ID: 19304470
[TBL] [Abstract][Full Text] [Related]
19. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
Houot R; Schultz LM; Marabelle A; Kohrt H
Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
[TBL] [Abstract][Full Text] [Related]
20. Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.
Chicaybam L; Bonamino MH
Int Rev Immunol; 2014 Oct; 33(5):402-16. PubMed ID: 24911925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
